Novo Nordisk A/S ADR buy StockNews.com
Start price
29.12.24
/
50%
€84.40
Target price
29.12.25
-
Performance (%)
-48.34%
End price
30.12.25
€43.60
Summary
This prediction ended on 30.12.25 with a price of €43.60. The BUY prediction by StockNews_com for Novo Nordisk A/S ADR performed very badly with a performance of -48.34%. Dividends of €1.10 are taken into consideration when calculating the performance. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 0.780% | 0.780% | -43.433% |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€102.50
14.12.24
14.12.24
-
14.12.25
14.12.25
-58.15%
15.12.25
15.12.25
